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Abstract
The burden of severe pneumonia in terms of morbidity and mortality is unknown in India
especially at sub-national level. In this context, we aimed to estimate the number of severe
pneumonia episodes, pneumococcal pneumonia episodes and pneumonia deaths in chil-
dren younger than 5 years in 2010. We adapted and parameterized a mathematical model
based on the epidemiological concept of potential impact fraction developed CHERG for
this analysis. The key parameters that determine the distribution of severe pneumonia epi-
sode across Indian states were state-specific under-5 population, state-specific prevalence
of selected definite pneumonia risk factors and meta-estimates of relative risks for each of
these risk factors. We applied the incidence estimates and attributable fraction of risk fac-
tors to population estimates for 2010 of each Indian state. We then estimated the number of
pneumococcal pneumonia cases by applying the vaccine probe methodology to an existing
trial. We estimated mortality due to severe pneumonia and pneumococcal pneumonia by
combining incidence estimates with case fatality ratios from multi-centric hospital-based
studies. Our results suggest that in 2010, 3.6 million (3.3–3.9 million) episodes of severe
pneumonia and 0.35 million (0.31–0.40 million) all cause pneumonia deaths occurred in
children younger than 5 years in India. The states that merit special mention include Uttar
Pradesh where 18.1% children reside but contribute 24% of pneumonia cases and 26%
pneumonia deaths, Bihar (11.3% children, 16% cases, 22% deaths) Madhya Pradesh
(6.6% children, 9% cases, 12% deaths), and Rajasthan (6.6% children, 8% cases, 11%
deaths). Further, we estimated that 0.56 million (0.49–0.64 million) severe episodes of
pneumococcal pneumonia and 105 thousand (92–119 thousand) pneumococcal deaths
occurred in India. The top contributors to India’s pneumococcal pneumonia burden were
Uttar Pradesh, Bihar, Madhya Pradesh and Rajasthan in that order. Our results highlight the
need to improve access to care and increase coverage and equity of pneumonia preventing
vaccines in states with high pneumonia burden.
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Introduction
Pneumonia is one of the most common causes of morbidity and mortality in children younger
than 5 years in India[1]. The Millennium Development Goal (MDG) 4, which focuses on
reduction of under-five mortality[2], has generated significant momentum for accurate assess-
ment of cause-specific under five morbidity and mortality. In 2004, global estimates on inci-
dence of clinical pneumonia in children younger than 5 years were first generated and
published by Rudan et al.[3]. For developing countries, these estimates suggested that median
incidence was 0.28 episodes per child-year, with an interquartile range 0.21–0.71 episodes per
child-year[3]. In 2008, the Child Health Epidemiology Reference Group (CHERG) established
by the World Health Organization (WHO) revised the estimates of childhood pneumonia
morbidity and mortality and also identified lack of exclusive breastfeeding, under-nutrition,
indoor air pollution, low birth weight, crowding and lack of measles immunization as leading
risk factors contributing to pneumonia incidence. In addition, they mentioned that five coun-
tries where 44% of the world’s children aged less than 5 years live (India, China, Pakistan, Ban-
gladesh, Indonesia, Nigeria) contribute more than half of the new pneumonia cases annually.
For India, they predicted around 43 million pneumonia cases (23% of the world’s total) and
estimated an incidence of 0.37 episodes per child-year for clinical pneumonia[4].
One of the major contributors to the pneumonia burden is Streptococcus pneumonia; others
includeHemophilus influenzae, Respiratory syncitical virus and Influenza. However, the estima-
tion of pneumococcal pneumonia among clinical pneumonia episodes has remained a challenge
in developing nations due to lack of laboratory diagnostic support and surveillance systems to
capture the etiologic agents for pneumonia. Also, the majority of pneumococcal pneumonia
infections are not bacteraemic, and hence not identifiable through cultures of sterile site body
fluids[5]. To address these limitations and to estimate the true burden of vaccine preventable
diseases, the vaccine probe approach has emerged as a promising alternative. In this approach,
the burden of pneumonia prevented by a specific vaccine is presumed to be a minimum esti-
mate of the burden of pneumonia due to the organism against which the vaccine is directed[6].
Using this approach, O’Brien et al. estimated burden of disease caused by Streptococcus pneu-
moniae in children younger than 5 years by applying efficacy estimates derived from pneumo-
coccal vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and
deaths.[5]. In 2013, Walker et al. published the first ever global estimates of the contribution of
other vaccine-preventable causes (Streptococcus pneumoniae,Haemophilus influenzae and
influenza) of severe clinical pneumonia cases and deaths using the same approach[7].
However, one of the limitations of the above global pneumonia estimates[3–5, 7] was focus
onWHO regions instead of the member states. This limitation has been addressed partly by
Rudan et al.[8] in their revised estimates on incidence, severe morbidity, mortality, underlying
risk factors and causative pathogens of clinical pneumonia for 192 countries. However, for a
large country like India, estimates of pneumonia burden at sub-national (states) level are still
not available. It is recognized that for India, which accounts for 23% of the global pneumonia
burden and 36% of the WHO regional burden, national estimates may hide significant sub-
national disparities[1, 4]. For example, a large nationally representative survey has reported
that in 2005, pneumonia contributed 13.5% of deaths in children age 1–59 months. However,
it was observed that the girls in central India had a five-times higher mortality rate (per 1000
live births) from pneumonia than did boys in south India[9]. Further, the lack of reliable esti-
mates of pneumonia burden in terms of etiology has led to under-utilization of existing preven-
tive interventions. In this context, we have generated Indian state-specific estimates for burden
of severe pneumonia, pneumococcal pneumonia and pneumonia deaths to provide guidance
for pneumonia control program.
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Methods
To estimate the number of new episodes of severe pneumonia for each Indian state we have
adapted and parameterized a model that was originally developed and validated by the
CHERG group[4] using Microsoft Excel. The model is based on the epidemiological concept of
potential impact fraction[10] as follows:
Νe=cy ¼ Pop < 5yrsð Þ  IncIndð Þ
 1þ
X
RF¼ 1!nð Þ PrevRFn  PrevRFnIndð Þ  RRRFn  1ð Þ½ 
n o
where Ne/cy is the number of new episodes of severe pneumonia per year in each Indian state,
Pop< 5yrs is the population of children less than 5 years in each state, IncInd is the estimated
incidence of severe clinical pneumonia at the all-India level, PrevRFn is the prevalence of expo-
sure to n-th risk factor among under-ﬁves in the Indian state, PrevRFnInd is the prevalence of
exposure to n-th risk factor among under-ﬁves at all India level and RRRFn is the relative risk
for developing pneumonia associated with the n-th risk factor.
The methods and model used to estimate and distribute the annual number of severe pneu-
monia episodes and pneumococcal pneumonia episodes has been explained in detail in a subse-
quent section. In addition, the parameter values and associated data sources are also explained.
Step 1
The total number of severe pneumonia episodes in children age less than 1 year was estimated
by multiplying the number of all children age less than 1 year living in each Indian state in year
2010 by an incidence of 0.068 severe pneumonia episodes per child-year.
The data on population for each Indian state for year 2010 (with one-year age interval) was
collected from Census of India[11] whereas the incidence of severe pneumonia in children age
less than 1 year was estimated through meta-analysis of selected population based cohort stud-
ies[12–14] that have used WHO-defined chest-radiography-positive pneumonia in case defini-
tion. However, the incidence rate of severe pneumonia for other age intervals (1–2 years, 2–3
years, 3–4 years and 4–5 years) was estimated through fitting data from hospital based multi-
centric surveillance study[15, 16] to an appropriate distribution (gamma). The incidence esti-
mates were adjusted to account for access to health services. The information regarding access
to health services was imputed from District Level Household and Facility Survey (DLHS-3)
which is a nationwide survey covering 601 districts from 34 states and union territories of
India[17]. Finally, the total number of severe pneumonia episodes in children age less than 5
years was calculated as sum total of all severe pneumonia episodes across all age intervals,
which was estimated through repeating the process, mentioned above for other age intervals
(1–2 years, 2–3 years, 3–4 years and 4–5 years) (S1 File).
Step 2
The total number of severe pneumonia episodes in children age less than 5 years estimated
from step 1 were then distributed into state-specific estimates on the basis of three parameters
(a) state-specific under-5 population, (b) state-specific prevalence of selected definite pneumo-
nia risk factors (prevalence of malnutrition (weight–for–age z<–2), low birth weight (2500
g), non–exclusive breastfeeding (in the first 4 months) and solid fuel use (‘yes’) and (c) meta-
estimates of relative risks for each of these risk factors[4].
The information on prevalence of the definite risk factors was available through National
Family Health Survey-3 (NFHS) [18]. The NFHS surveys are conducted every 5–6 years under
the stewardship of the Ministry of Health and Family Welfare (MOHFW), Government of
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India. The survey is based on a sample of households that is representative at the national and
state levels and provides trend data on key indicators. The key risk factors included in the
model—i.e. prevalence of malnutrition, low birth weight, non–exclusive breastfeeding and
solid fuel use—have consistently shown significant effects in multivariate study designs [4, 7, 8,
19, 20]. The meta-estimates of relative risks (RR) for the selected definite risk factors were
taken from an earlier study[4] as follows: malnutrition-(RR-1.8), low birth weight (RR-1.4),
non-exclusive breastfeeding (RR-1.9) and indoor air pollution (RR-1.8).
Step 3
The total number of pneumococcal pneumonia episodes was estimated by applying attribut-
able proportion of 36.51% for Streptococcus pneumoniae [5]to all-cause severe pneumonia epi-
sodes in children age less than 5 years across Indian states estimated from step 2.
To determine the proportions of pneumonia cases attributable to Streptococcus pneumoniae,
we relied on pneumococcal conjugate vaccine efficacy trial conducted in Philippines, which
was the only trial conducted in Asia[21]. This trial was conducted in 2000 prior to introduction
of Hib in Philippines (2010), so prevalence of non-pneumococcal causes of pneumonia was
likely to be similar. The efficacy of the vaccine against a relevant definition of pneumonia was
adjusted to account for vaccine serotype coverage and efficacy against pneumococcal pneumo-
nia. We used the conjugate vaccine efficacy against WHO-defined chest-radiography-positive
pneumonia as a measure of the proportion of pneumonia cases attributable to S pneumoniae.
The Philippines trial reported 19.8% efficacy against radiologic pneumonia ((95% CI: -8.8,
40.8) in children age less than 1 year. The 11 serotypes contained in the vaccine (1, 3, 4, 5, 6B,
7F, 9V, 14, 18C, 19F and 23F) were estimated to account for 65.33% of Invasive Pneumococcal
Disease (IPD) in the India based on a multi-centric surveillance study[22]. With vaccine effi-
cacy against vaccine-type pneumococcal disease assumed to be 83%[23], we estimated that
23.8% (= 19.8/83) of radiologic pneumonia cases are due to the 11-pneumococcal serotypes in
the vaccine and 36.51% due to any pneumococcal serotypes. Hence, radiologic pneumonia
cases attributable to S Pneumoniae were 36.51%.
Step 4
To estimate and distribute all-cause pneumonia mortality and pneumococcal pneumonia mor-
tality in children age less than 5 years, the case fatality rate of 1.95% in severe pneumonia was
applied to all-cause severe pneumonia episodes estimated in step 2 and the case fatality rate of
16.7% in pneumococcal pneumonia was applied to pneumococcal pneumonia episodes esti-
mated in step 3. These mortality estimates in children age less than 5 years were estimated
from multi-centric hospital based studies[14, 24] and were scaled across Indian states in accor-
dance with pneumonia mortality rates reported by Million Death Study for India[1]. The
parameterized model is provided as supplementary material (S1 File).
Results
We estimated that in year 2010, 3.6 million (3.3–3.9 million) episodes of severe pneumonia
and 0.35 million (0.3–0.4 million) pneumonia deaths (all-cause) occurred in children younger
than 5 years in India (Table 1). The estimated incidence of severe pneumonia was 30.7 (95%
CI, 28.1–33.5) per 1000 children per year in those less than 5 years of age, and 87.3 (95% CI,
80.1–95.2) in children aged less than 1 year.
Further, we conducted a disaggregated state-specific analysis for 29 states of India. The esti-
mated annual severe pneumonia incidence varied greatly from one state to another: 7.2 epi-
sodes (95% CI, 6.6–7.8) per 1000 children in Manipur to 50.3 episodes (95% CI, 46.2–54.9) per
Modelling Based Estimates for Pneumococcal Pneumonia for Indian States
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1000 children in Jharkhand. We observed that southern states (Kerala, Tamil Nadu) and north-
eastern states (Sikkim, Manipur) have significantly lower incidence and mortality from severe
pneumonia as compared to rest of the India (Table 1). In age-stratified analysis, we observed
that severe pneumonia related morbidity followed a skewed distribution: highest morbidity in
the 0–1 year age group (51%) followed by the 1–2 year age group (22%) (S1 File).
We estimated that Jharkhand had the highest incidence of severe pneumonia but Uttar Pra-
desh (UP) had the highest number of cases because of a large population of children younger
Table 1. Distribution of severe pneumonia and pneumococcal pneumonia episodes and deaths in children younger than 5 years in 2010, across
Indian states.
Indian State Population
aged 0–5
years
Severe
Pneumonia
Incidence*
Severe Pneumonia
Episodes
(Thousands)
Pneumonia
Deaths
(Thousands)
Pneumococcal
Pneumonia Episodes
(Thousands)
Pneumococcal
Pneumonia Deaths
(Thousands)
North Delhi 1381200 8.0 (7.3–8.7) 11.0 (10.1–12.0) 0.6 (0.6–0.7) 1.7 (1.5–2.0) 0.2 (0.2–0.2)
Haryana 2362519 28.0 (25.7–30.5) 66.2 (60.7–70.2) 4.8 (4.2–5.5) 10.4 (9.1–11.9) 1.4 (1.2–1.6)
Himachal
Pradesh
544984 18.6 (17.1–20.3) 10.1 (9.3–11.1) 0.7 (0.6–0.8) 1.6 (1.4–1.8) 0.2 (0.2–0.2)
Jammu &
Kashmir
1414884 17.2 (15.8–18.8) 24.4 (22.4–26.6) 2.0 (1.7–2.3) 3.8(3.4–4.4) 0.6 (0.5–0.7)
Punjab 2133529 21.9 (20.1–23.9) 46.8 (42.9–51.0) 2.1 (1.8–2.4) 7.4 (6.5–8.4) 0.6 (0.5–0.7)
Rajasthan 7302170 38.1 (35.0–41.6) 278.3 (255.3–303.4) 40.3 (35.2–46.1) 43.9 (38.5–50.1) 11.9 (10.4–13.6)
Uttaranchal 924864 28.1 (25.8–30.6) 26.0 (23.8–28.3) 2.9 (2.5–3.3) 4.1 (3.6–4.7) 0.9 (0.7–1.0)
Central Chhattisgarh 2541065 28.2 (25.8–30.7) 71.6 (65.7–78.1) 7.1 (6.2–8.1) 11.3 (9.9–12.9) 2.1 (1.8–2.4)
Madhya
Pradesh
7471286 44.3 (40.7–48.3) 331.2 (303.7–361.1) 44.2 (38.7–50.5) 52.2 (45.8–59.6) 13.4 (11.4–14.9)
Uttar Pradesh 20376668 41.4 (38.0–45.2) 844.0 (774.1–920.2) 94.2 (82.4–107.7) 133.2 (116.7–151.9) 27.8 (24.4–31.7)
East Bihar 12765029 45.5 (41.7–49.6) 580.4 (532.3–632.8) 78.6 (68.8–89.9) 91.6 (80.3–104.5) 23.2 (20.3–26.5)
Jharkhand 3648297 50.3 (46.2–54.9) 183.6 (168.4–200.2) 21.3 (18.7–24.4) 29.0 (25.4–33.1) 6.3 (5.5–7.2)
Orissa 3653029 36.4 (33.4–39.7) 133.0 (122.0–145.0) 11.6 (10.1–13.2) 21.0 (18.4–23.9) 3.4 (3.0–3.9)
West Bengal 7333143 27.8 (25.5–30.3) 203.7 (186.8–222.1) 9.9 (8.6–11.3) 32.1 (28.2–36.7) 2.9 (2.6–3.3)
North
East
Arunachal
Pradesh
142879 14.5 (13.3–15.8) 2.1 (1.9–2.3) 0.1 (0.1–0.1) 0.3 (0.3–0.4) 0.0 (0.0–0.0)
Assam 3212833 27.3 (25.0–29.7) 87.6 (80.3–95.5) 7.6 (6.6–8.6) 13.8 (12.1–15.8) 2.2 (2.0–2.5)
Manipur 232029 26.7 (24.5–29.1) 6.2 (5.7–6.8) 0.3 (0.3–0.3) 1.0 (0.9–1.1) 0.1 (0.1–0.1)
Meghalaya 406154 25.2 (23.1–27.5) 10.2 (9.4–11.2) 0.5 (0.4–0.6) 1.6 (1.4–1.8) 0.1 (0.1–0.2)
Mizoram 121233 7.2 (6.6–7.8) 0.9 (0.8–0.9) 0.0 (0.0–0.0) 0.1 (0.1–0.2) 0.0 (0.0–0.0)
Nagaland 197262 33.1 (30.3–36.1) 6.5 (6.0–7.1) 0.3 (0.3–0.4) 1.0 (0.9–1.2) 0.1 (0.1–0.1)
Sikkim 42336 9.6 (8.8–10.5) 0.4 (0.4–0.4) 0.0 (0.0–0.0) 0.1 (0.1–0.1) 0.0 (0.0–0.0)
Tripura 322566 28.8 (26.4–31.4) 9.3 (8.5–10.1) 0.5 (0.4–0.5) 1.5 (1.3–1.7) 0.1 (0.1–0.2)
West Goa 101203 11.9 (10.9–13.0) 1.2 (1.1–1.3) 0.1 (0.1–0.1) 0.2 (0.2–0.2) 0.0 (0.0–0.0)
Gujarat 5460332 26.4 (24.2–28.8) 144.1 (132.2–157.1) 8.7 (7.6–10.0) 22.7 (19.9–25.9) 2.6 (2.3–2.9)
Maharashtra 9362026 16.2 (14.9–17.7) 152.0 (139.4–165.8) 6.7 (5.7–7.6) 24.0 (21.0–27.4) 2.0 (1.7–2.2)
South Andhra
Pradesh
6284765 23.2 (21.3–25.3) 145.9 (133.9–159.1) 5.5 (4.8–6.3) 23.0 (20.2–26.3) 1.6 (1.4–1.9)
Karnataka 5046719 19.5 (17.8–21.2) 98.2 (90.1–107.1) 4.7 (4.1–5.4) 15.5 (13.6–17.7) 1.4 (1.2–1.6)
Kerala 2453092 11.5 (10.5–12.5) 28.2 (25.9–30.7) 0.2 (0.1–0.2) 4.4 (3.9–5.1) 0.0 (0.0–0.1)
Tamil Nadu 5278701 13.8 (12.7–15.1) 73.0 (66.8–79.5) 1.0 (0.8–1.1) 11.5 (10.1–13.1) 0.3 (0.3–0.3)
All India 112516797 30.7 (28.1–33.5) 3576.0 (3279.8–
3898.9)
356.3 (311.6–
407.4)
564.2 (494.5–643.8) 105.1 (92.1–120.0)
Data in parenthesis are 95% conﬁdence intervals
* Incidence in children aged 0–59 months per 1000 children younger than 5 years
doi:10.1371/journal.pone.0129191.t001
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than 5 years. The states that merit special mention include Uttar Pradesh (UP) from central
India where 18.1% children reside but contribute 24% of pneumonia cases, Bihar (eastern
India, 11.3% children, 16% of cases), Madhya Pradesh (MP) (central India, 6.6% children, 9%
of cases), and Rajasthan (northern India, 6.6% children, 8% of cases). We observed that the dis-
tribution of pneumonia mortality among across Indian states followed a trend similar to that
of severe pneumonia (Fig 1A). Of 3.6 million episodes of severe pneumonia and 0.35 million
deaths that occurred in children aged less than 5 years in India, the top five contributors were
UP (24% of cases and 26% of deaths), followed by Bihar (16% of cases, 22% of deaths), MP (9%
of cases, 12% of deaths), Rajasthan (8% of cases, 11% of deaths) and Jharkhand (5% of cases,
6% of deaths) as top five contributors (Fig 1B).
Further, we estimated that in year 2010, 0.56 million (0.49–0.64 million) severe pneumococ-
cal pneumonia episodes and 105 thousand (92–119 thousand) pneumococcal pneumonia
deaths had occurred in children younger than 5 years of age in India. The annual incidence of
severe pneumococcal pneumonia in India was estimated to be 4.8 episodes (95% CI, 4.2–5.5)
per 1000 children younger than 5 years. The top five contributors to India’s pneumococcal
pneumonia burden in terms of number of cases and deaths were again Uttar Pradesh (1,33,167
cases 27, 785 deaths), Bihar (91,578 cases, 23,202 deaths) Madhya Pradesh (52,250 cases, 13,043
deaths), Rajasthan (43,911 cases, 11,889 thousand death) and Jharkhand (28,969 cases, 6296
deaths) (Fig 2). The incidence estimate for pneumococcal pneumonia episodes was highest in
Jharkhand (7.9 episodes per 1000 child) and lowest in Manipur (1.1 episodes per 1000 child)
It is recognized that severe pneumonia has a higher proportion of cases attributable to S.
pneumonia, and leads to more severe outcomes. It is thus preferred for use in estimating the
burden of pneumonia. We also observed that the burden of clinical pneumonia was signifi-
cantly higher than severe pneumonia: of all clinical pneumonia cases, 21.2% (95% CI, 18.0–
24.9) were classified as severe, and we estimated that the proportion of pneumococcal pneumo-
nia among all severe pneumonia was 15.8% whereas pneumococcal pneumonia deaths among
all cause pneumonia deaths were 29.5%. Finally, we estimated a case fatality rate in severe
pneumonia of 9.96%, comparable to case fatality rates of 10.8% reported in earlier estimates[8].
Discussion
It is recognized that interpretation of country level pneumonia estimates is challenging, espe-
cially for large countries like India and China because clinical pneumonia incidence, access to
care and childhood mortality vary substantially within the country[5]. We have attempted to
Fig 1. Distribution of severe pneumonia episodes and pneumonia deaths in children younger than 5
years in India. (A) Number of severe pneumonia episodes in children aged 0–59 months (B) Number of
pneumonia deaths in children aged 0–59 months.
doi:10.1371/journal.pone.0129191.g001
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address this limitation by generating state specific estimates on burden of severe pneumonia,
pneumococcal pneumonia and pneumonia related mortality. Our pneumonia estimates are
based on the epidemiological concept of potential fraction of key risk factors for pneumonia.
Hence, our estimates capture the impact of varying levels of prevalence of key risk factors
across different states in India. Also, varying degree of access to care across states has been cap-
tured in the model (S1 File). Further, the pneumococcal pneumonia estimates are based on
applying a vaccine probe approach to an existing trial (see methods). The primary reason for
adopting this approach is recognition of the fact that until new diagnostic methods become
available, models using the vaccine probe approach are reliable in estimating cause-specific
pneumonia disease burden[5].
To check the consistency and plausibility of severe pneumonia estimates generated by our
model we compared them against other published estimates for India. We estimated 3.6 million
episodes of severe pneumonia in children younger than 5 years for the year 2010, which was
similar to the estimate of 4.0 million episodes reported by CHERG for India [8]. Further, our
model predicted severe pneumonia incidence of 30.7 episodes per 1000 child per-year, which
was similar to incidence reported by the CHERG (32.0 episodes per 1000 child per-year) [8].
The methodological and modelling approach adopted by CHERG group and our group were
essentially the same. They key difference was in the parameter values as explained in methodol-
ogy section. We also checked the plausibility of state-specific estimates for pneumococcal pneu-
monia. Our model predicted a pneumococcal disease incidence of 4.4 (95% CI, 3.8–5.0) cases
Fig 2. Selected Indian states with the highest number of pneumococcal pneumonia deaths in children younger than 5 years in 2010. Bubble size
indicates the number of pneumococcal pneumonia deaths.
doi:10.1371/journal.pone.0129191.g002
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per 1000 in children younger than 5 years of age. This was similar to an invasive pneumococcal
disease rate of 4.5 cases per 1000 children reported from neighboring geographical area of Ban-
gladesh by a population-based, active-surveillance, and active-case detection study[25].
In the state-specific analysis we observed that in general, the states having a high prevalence
of pneumonia risk factors and poor access to health services had a higher burden of pneumonia
cases and deaths[17, 18]. This is consistent with reports of successive national health surveys
highlighting that poor health infrastructure and health services, poor percentage of institutional
deliveries, low immunization coverage rates and other health system weaknesses have led to
high pneumonia burden in these states[17, 18, 20, 26] especially UP, Bihar, MP and Rajasthan.
With reference to the contribution of pneumococcal pneumonia to severe pneumonia epi-
sodes, we estimated a pneumococcal pneumonia contribution of 15.8% to all-cause severe
pneumonia, as compared to 18.4% reported by Rudan et al. [7, 8]. This difference possibly
occurred because of differing methodological approaches for the estimation of attributable pro-
portion. Within the framework of the vaccine probe approach, other researchers (Rudan et al,
O’ Brien et al and Walker et al.) have used the conjugate vaccine efficacy against WHO-defined
clinical pneumonia as a measure of the proportion of pneumonia cases attributable to S. pneu-
moniae[5]. Our group has used the conjugate vaccine efficacy against WHO-defined chest-
radiography-positive pneumonia as a measure of the proportion of pneumonia cases attribut-
able to S. pneumonia, with adjustment for vaccine serotype distribution across the India.
Finally, our estimate of contribution of S. pneumoniaemortality (29.5%) to all cause pneumo-
nia mortality is similar to that estimated by other researchers (32.9%)[7, 8].
Our national and state-specific estimates were generated using the same statistical model
based on the epidemiological concept of potential impact fraction. Hence, the comparability of
our national level estimates with other studies provides reasonable confidence that state level
estimates for severe pneumonia, pneumococcal pneumonia and pneumonia deaths are also
robust. Furthermore, we are reasonably confident of our age-specific estimates of pneumonia
morbidity and mortality. We observed that the distribution of pneumonia cases and deaths fol-
lowed a right skewed distribution with the highest burden in the youngest age group, and it
then decreases in older groups[15]. Our findings are consistent with community based longitu-
dinal cohorts and multi-centric surveillance studies from India reporting skewed distribution
of pneumonia burden [12, 13, 22, 24, 27, 28].
One of methodological limitations of our model is that it does not necessarily assume that
the risk factors are independent, because we applied a meta-estimate of relative risks derived
primarily from the studies of multivariate design[29]. Also, our child population estimates
were for the year 2010, the prevalence of exposures to risk factors was for the years 2006–07,
and the childhood pneumonia estimates were based on studies conducted between 2007–2010.
Hence, the estimates for pneumonia may be an over-estimate because the prevalence of risk
factors has decreased, and access to care has increased over the last decade[7, 8]. Another
potential factor that could contribute to an overestimate is availability of pneumococcal conju-
gate vaccines (PCV) in India. Although the PCV is available in the private sector since 2008,
the coverage is negligible (<1% in major states) and the vaccine has not yet been introduced
into the universal immunization programme.[30]
Another potential limitation of our study is the fact that other researchers assume that indi-
vidual estimates of cause-specific etiologies for pneumonia add up to a total estimated pneu-
monia envelope because we have not attempted to do the same[7, 8]. The focus of our study
was to offer insights into the actual distribution of severe pneumonia, pneumococcal pneumo-
nia and pneumonia deaths to inform policy on pneumonia prevention and control. It is recog-
nized that pneumonia related morbidity and mortality are good indicators of the economic
burden of pneumonia, since households incur significant healthcare cost and productivity
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losses as a result of hospitalization due to pneumonia[31]. Information on the burden of severe
pneumonia in different age groups and across all states in India would be helpful in designing
and delivering targeted interventions to specific populations.
Finally, the use of conjugate vaccines against pneumonia, especially Streptococcus pneumo-
nia and Hemophilius influenza, appears to be warranted for the prevention pneumonia mor-
bidity and mortality in children younger than 5 years. In India, state specific estimates of the
pneumonia burden and mortality could be used to identify states where vaccination and other
interventions are required; and age specific estimates could help identify at what age vaccines
should be used to achieve highest impact [15]. Adopting this practice would accelerate progress
towards MDG4, and would also contribute to a reduction in regional disparities of child health
indicators.
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